Clinical Trial

Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan

Study acronym: TREAT-HF
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
To determine feasibility of recruitment and tolerability of treatment with sacubitril-valsartan among adult age survivors of cancer diagnosed at or before age 39 who have stage B heart failure.
Protocol Amendment History 3 changes
notable Enrollment increased: 53 -> 70 participants 2026-07-09
minor Trial arms changed: 2 -> 3 2026-07-09
notable Primary completion pushed: 2027-11-30 -> 2028-11-30 2026-07-09
Trial Details
NCT Number NCT05194111
Lead Sponsor Virginia Commonwealth University
Conditions Heart Failure, Heart Dysfunction
Enrollment 70 participants
Start Date 2022-08-11
Primary Completion 2028-11-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-08